Thus, focusing on TLR4/MD2‐MyD88 complex formation and signalling axis is gaining increasing interest as a potential therapeutic or preventive strategy for the treatment of AMI‐induced HF. The gene discussed is MYD88; the disease is hydrops fetalis.